News

Shinobi Therapeutics Secures $59M Grant from the Japanese Agency for Medical Research and Development

Shinobi Therapeutics, the biotechnology company developing a new class of immune evasive iPS cell therapies, today announced that it has been awarded up to $59M in non-dilutive grant funding by the Japanese Agency for Medical Research and Development (AMED). The grant will be used to support the...

Bayer and Alara Imaging Announce Collaboration

Bayer has announced an exploratory collaboration with Alara Imaging at the annual AHRA (American Healthcare Radiology Administrators) conference. UCSF Innovation Ventures congratulates Rebecca Smith-Bindman, the lead UCSF inventor. MORE

The fifth annual pitch competition, Equalize Startups, turned 5 this year

On June 20th, Osage University, in partnership with Equalize Startups, celebrated the 5th annual pitch competition. Equalize Startups is dedicated to advancing female talent in academia-driven startups. The competition showcased remarkable innovators across Med Tech, Physical Sciences, Digital...

Montara Therapeutics Closes $8 Million Seed Round to Develop Safer, More Effective Neuroscience Drugs Using a Novel Brain-Only Pharmacology Approach

Montara Therapeutics, a therapeutics company aiming to revolutionize the discovery and development of brain-targeting drugs, announced today the closing of an oversubscribed $8 million seed financing led by SV Health Investors’ Dementia Discovery Fund and co-lead Two Bear Capital. Dolby Family...

Linus Health Acquires Together Senior Health to Expand its Platform to Better Serve Patients and Providers with End-to-end Workflow Capabilities

Linus Health, a digital health company enabling early detection of cognitive impairment, Alzheimer’s, and other dementias, today announced its acquisition of Together Senior Health (Together), a brain health company delivering evidence-based solutions for individuals with cognitive decline,...

Exai Bio Appoints New Chief Executive Officer

Exai Bio, a next-generation oncRNA- and generative AI-based liquid biopsy company, today announced the appointment of Dave Daly as Chief Executive Officer. With more than 30 years of cancer diagnostics and executive leadership experience, including at Thrive Earlier Detection (acquired by Exact...

PreludeDx™ and Cancer Help Desk Announce Collaboration to Support Women Diagnosed with DCIS Breast Cancer

Prelude Corporation a breast cancer precision diagnostics company, and Cancer Help Desk, have partnered to provide expert nurse navigation services for women diagnosed with ductal carcinoma in situ (DCIS) breast cancer.

Rezo Therapeutics Appoints Cristiana Guiducci, Ph.D., as Chief Scientific Officer

Rezo Therapeutics, a biotechnology company pioneering the integrated mapping of disease networks for precision therapeutics, today announced the appointment of Cristiana Guiducci, Ph.D., as chief scientific officer. Dr. Guiducci previously served as senior vice president of immunology and oncology...

Fostering health AI development with confidential computing

In 2020, the University of California, San Francisco (UCSF) Center for Digital Health Innovation (CDHI), Fortanix, Intel, and Microsoft Azure formed a collaboration to create a privacy-preserving confidential computing platform to accelerate clinical algorithm development and validation.

Illumina acquires Fluent BioSciences to accelerate single-cell analysis and discovery to a broader customer base

Illumina, a global leader in DNA sequencing and array-based technologies, announced that effective today it has acquired Fluent BioSciences, developer of an emerging and highly differentiated single-cell technology.   More